RELATED STUDY

Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.

Key Findings:  In this study of moderately active Crohn's disease, CBD was safe but had no beneficial effects. This could be due to lack of effect of CBD on Crohn's disease, but could also be due to the small dose of CBD, the small number of patients in the study, or the lack of the necessary synergism with other cannabinoids. Further investigation is warranted.

Type of Study:  Double Blind Clinical Trial

Study Sample Size:  20

Study Result:  Inconclusive

Study Location(s):  Israel

Year of Pub:  2017


Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Unspecified

Chemotype:  Chemotype III

Sub-Ratio: 0:1 (THC:CBD)

Dosage: CBD (10 mg) or placebo 2x daily.

Route of Administration:  Oral (Ingestion)



Link to study